Report Detail
Global Danoprevir Sodium Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4706156 |
- 09 June, 2026 |
- Global |
- 81 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Danoprevir Sodium market size was valued at US$ 1852 million in 2025 and is forecast to a readjusted size of US$ 229 million by 2032 with a CAGR of 18.6% during review period.
In 2025, global Danoprevir Sodium production reached approximately 23,000 units.Danoprevir Sodium (brand name: Ganovo), independently developed by Ascletis Pharma, is China’s first domestically originated Class 1 chemical anti‑hepatitis C virus (HCV) drug. Classified as a new‑generation NS3/4A protease inhibitor among direct‑acting antivirals (DAAs), it is an achievement of the national Major New Drug Creation Project. Approved by the NMPA in June 2018, it is indicated for the targeted antiviral treatment of chronic hepatitis C.
Danoprevir Sodium is an NS3/4A protease inhibitor targeting hepatitis C virus (HCV), typically used in combination with other direct-acting antivirals (DAAs), and has an established application base in China’s HCV antiviral treatment market. With the continued advancement of the national “hepatitis C elimination” strategy and improvements in screening and diagnosis rates, treatment demand is being progressively released, providing a stable market opportunity for this drug.
From a competitive landscape perspective, pan-genotypic DAA regimens centered on Sofosbuvir, along with imported originator products, still dominate the market. However, danoprevir sodium, leveraging its domestic R&D background, pricing advantages, and value in specific combination regimens, demonstrates a certain level of competitiveness in selected patient populations.
On the policy side, national reimbursement negotiations and volume-based procurement continue to drive down drug prices, while significantly improving treatment accessibility and accelerating market uptake. From a competitive standpoint, the launch of multiple new DAA combination regimens is intensifying market competition. Therefore, the future market performance of danoprevir sodium will depend on its clinical positioning within combination therapies, the accumulation of real-world efficacy and safety data, and its overall competitiveness in pricing, distribution channels, and reimbursement coverage.
This report is a detailed and comprehensive analysis for global Danoprevir Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Danoprevir Sodium market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Danoprevir Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Danoprevir Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Danoprevir Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Danoprevir Sodium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Danoprevir Sodium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ascletis Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Danoprevir Sodium market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100 mg/tablet
200 mg/tablet
Market segment by Dosage form
Tablet
Capsule
Market segment by Release type
Immediate-release (IR)
Sustained-release (SR)
Market segment by Application
Treatment-naïve Adult Patients With Chronic hepatitis C
Non-cirrhotic Population
Confirmed HCV Genotype 1b Infection
Others
Major players covered
Ascletis Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Danoprevir Sodium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Danoprevir Sodium, with price, sales quantity, revenue, and global market share of Danoprevir Sodium from 2021 to 2026.
Chapter 3, the Danoprevir Sodium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Danoprevir Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Danoprevir Sodium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Danoprevir Sodium.
Chapter 14 and 15, to describe Danoprevir Sodium sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Danoprevir Sodium Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 100 mg/tablet
- 1.3.3 200 mg/tablet
- 1.4 Market Analysis by Dosage form
- 1.4.1 Overview: Global Danoprevir Sodium Consumption Value by Dosage form: 2021 Versus 2025 Versus 2032
- 1.4.2 Tablet
- 1.4.3 Capsule
- 1.5 Market Analysis by Release type
- 1.5.1 Overview: Global Danoprevir Sodium Consumption Value by Release type: 2021 Versus 2025 Versus 2032
- 1.5.2 Immediate-release (IR)
- 1.5.3 Sustained-release (SR)
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Danoprevir Sodium Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Treatment-naïve Adult Patients With Chronic hepatitis C
- 1.6.3 Non-cirrhotic Population
- 1.6.4 Confirmed HCV Genotype 1b Infection
- 1.6.5 Others
- 1.7 Global Danoprevir Sodium Market Size & Forecast
- 1.7.1 Global Danoprevir Sodium Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Danoprevir Sodium Sales Quantity (2021-2032)
- 1.7.3 Global Danoprevir Sodium Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Ascletis Pharma
- 2.1.1 Ascletis Pharma Details
- 2.1.2 Ascletis Pharma Major Business
- 2.1.3 Ascletis Pharma Danoprevir Sodium Product and Services
- 2.1.4 Ascletis Pharma Danoprevir Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Ascletis Pharma Recent Developments/Updates
3 Competitive Environment: Danoprevir Sodium by Manufacturer
- 3.1 Global Danoprevir Sodium Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Danoprevir Sodium Revenue by Manufacturer (2021-2026)
- 3.3 Global Danoprevir Sodium Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Danoprevir Sodium by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Danoprevir Sodium Manufacturer Market Share in 2025
- 3.4.3 Top 6 Danoprevir Sodium Manufacturer Market Share in 2025
- 3.5 Danoprevir Sodium Market: Overall Company Footprint Analysis
- 3.5.1 Danoprevir Sodium Market: Region Footprint
- 3.5.2 Danoprevir Sodium Market: Company Product Type Footprint
- 3.5.3 Danoprevir Sodium Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Danoprevir Sodium Market Size by Region
- 4.1.1 Global Danoprevir Sodium Sales Quantity by Region (2021-2032)
- 4.1.2 Global Danoprevir Sodium Consumption Value by Region (2021-2032)
- 4.1.3 Global Danoprevir Sodium Average Price by Region (2021-2032)
- 4.2 North America Danoprevir Sodium Consumption Value (2021-2032)
- 4.3 Europe Danoprevir Sodium Consumption Value (2021-2032)
- 4.4 Asia-Pacific Danoprevir Sodium Consumption Value (2021-2032)
- 4.5 South America Danoprevir Sodium Consumption Value (2021-2032)
- 4.6 Middle East & Africa Danoprevir Sodium Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Danoprevir Sodium Sales Quantity by Type (2021-2032)
- 5.2 Global Danoprevir Sodium Consumption Value by Type (2021-2032)
- 5.3 Global Danoprevir Sodium Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Danoprevir Sodium Sales Quantity by Application (2021-2032)
- 6.2 Global Danoprevir Sodium Consumption Value by Application (2021-2032)
- 6.3 Global Danoprevir Sodium Average Price by Application (2021-2032)
7 North America
- 7.1 North America Danoprevir Sodium Sales Quantity by Type (2021-2032)
- 7.2 North America Danoprevir Sodium Sales Quantity by Application (2021-2032)
- 7.3 North America Danoprevir Sodium Market Size by Country
- 7.3.1 North America Danoprevir Sodium Sales Quantity by Country (2021-2032)
- 7.3.2 North America Danoprevir Sodium Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Danoprevir Sodium Sales Quantity by Type (2021-2032)
- 8.2 Europe Danoprevir Sodium Sales Quantity by Application (2021-2032)
- 8.3 Europe Danoprevir Sodium Market Size by Country
- 8.3.1 Europe Danoprevir Sodium Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Danoprevir Sodium Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Danoprevir Sodium Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Danoprevir Sodium Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Danoprevir Sodium Market Size by Region
- 9.3.1 Asia-Pacific Danoprevir Sodium Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Danoprevir Sodium Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Danoprevir Sodium Sales Quantity by Type (2021-2032)
- 10.2 South America Danoprevir Sodium Sales Quantity by Application (2021-2032)
- 10.3 South America Danoprevir Sodium Market Size by Country
- 10.3.1 South America Danoprevir Sodium Sales Quantity by Country (2021-2032)
- 10.3.2 South America Danoprevir Sodium Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Danoprevir Sodium Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Danoprevir Sodium Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Danoprevir Sodium Market Size by Country
- 11.3.1 Middle East & Africa Danoprevir Sodium Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Danoprevir Sodium Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Danoprevir Sodium Market Drivers
- 12.2 Danoprevir Sodium Market Restraints
- 12.3 Danoprevir Sodium Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Danoprevir Sodium and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Danoprevir Sodium
- 13.3 Danoprevir Sodium Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Danoprevir Sodium Typical Distributors
- 14.3 Danoprevir Sodium Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Danoprevir Sodium. Industry analysis & Market Report on Danoprevir Sodium is a syndicated market report, published as Global Danoprevir Sodium Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Danoprevir Sodium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
